Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD,as Chief Medical OfficerPREV STORYAlimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors